Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

36.73 USD +0.03 (+0.08%)
Official Closing Price Updated: 7:59 PM EST, Jan 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Pfizer

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
99 100 Next >
Pfizer Outlines Five-Point Plan to Battle COVID-19
Pfizer today issued a five-point plan calling on the biopharmaceutical industry to join the company in committing to unprecedented collaboration to combat COVID-19. 
From Business Wire News Releases
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
Not intended for UK-based media 
From PR Newswire
Thinking about trading options or stock in Costco, Walt Disney, Facebook, Pfizer, or UnitedHealth?
InvestorsObserver issues critical PriceWatch Alerts for COST, DIS, FB, PFE, and UNH. 
From PR Newswire
New GeoMap Tools Get Patient Recruitment Back on Track During the COVID-19 Outbreak
From ACN Newswire
ViiV Healthcare presents positive long-term data from phase III study demonstrating efficacy and safety of cabotegravir and rilpivirine, its investigational, long-acting, injectable treatment regimen
ViiV HC presents positive long-term phase III study data demonstrating efficacy and safety of cabotegravir and rilpivirine in adults living with HIV-1 
From Business Wire News Releases
ViiV Healthcare presents positive 48-week data from phase III study showing every-two-month regimen of investigational long-acting, injectable cabotegravir and rilpivirine has similar efficacy to once
ViiV HC presents positive phase III study showing every-two-month regimen of cabotegravir and rilpivirine has similar efficacy to once-monthly dosing 
From Business Wire News Releases
ViiV Healthcare and UNC-Chapel Hill announce five-year renewal of innovative HIV cure partnership
ViiV Healthcare and UNC-Chapel Hill announce five-year renewal of innovative HIV cure partnership 
From Business Wire News Releases
Thinking about trading options or stock in Apple, Bank of America, Pfizer, Paypal, or Uber?
InvestorsObserver issues critical PriceWatch Alerts for AAPL, BAC, PFE, PYPL, and UBER. 
From PR Newswire
Global Market For Cancer Therapies Could Exceed US$220 Billion By 2025
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Market for Cancer Therapies Could Exceed US$220 Billion by 2025
Financialnewsmedia.com News Commentary 
From PR Newswire
Susan Hockfield Elected to Pfizer’s Board of Directors
Pfizer Inc. (NYSE: PFE) today announced the election of Dr. Susan Hockfield to its Board of Directors, effective immediately. Dr. Hockfield, age 68, was also appointed to the Regulatory and Compliance... 
From Business Wire News Releases
ViiV Healthcare initiates study with the University of South Carolina to evaluate the benefits of ride-sharing services on improving access to care for people living with HIV
ViiV HC initiates study with USC to evaluate the benefits of ride-sharing services on improving access to care for people living with HIV 
From Business Wire News Releases
U.S. FDA Accepts Regulatory Submission for Tanezumab, a Potential First-in-Class Treatment for Patients with Chronic Pain Due to Moderate-to-Severe Osteoarthritis
Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced that the U.S. Food and Drug Administration (FDA) accepted for review a Biologics License Application (BLA) for tanezumab 2.5... 
From PR Newswire
James Quincey Elected to Pfizer’s Board of Directors
Pfizer Inc. (NYSE: PFE) today announced the election of James Quincey to its Board of Directors, effective immediately. Mr. Quincey, age 55, was also appointed to the Compensation Committee and the... 
From Business Wire News Releases
Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer
- Pfizer's Upjohn Division CFO Sanjeev Narula selected for leadership role at combined company - 
From PR Newswire
Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer
Mylan N.V. (NASDAQ: MYL) and Pfizer (NYSE: PFE) today announced that Sanjeev Narula, current chief financial officer (CFO) of Upjohn, a division of Pfizer, has been named incoming CFO of Viatris, the... 
From Business Wire News Releases
Mylan and Pfizer Finalize Appointments to Viatris Board of Directors
13 Inaugural Directors Bring Wide-Ranging Experience, Expertise and a Focus on Driving Shareholder Value 
From PR Newswire
Mylan and Pfizer Finalize Appointments to Viatris Board of Directors
Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced the remaining appointees to the inaugural 13-member Board of Directors for Viatris, the new company that will result from the... 
From Business Wire News Releases
Basilea reports the launch of antifungal Cresemba® (isavuconazole) in Australia triggering the first milestone payment related to Asia-Pacific
From GlobeNewswire News Releases
Study Shows Surprisingly Low Number of Patients Seek Trials to Treat Cancer
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Study Shows Surprisingly Low Number of Patients Seek Trials to Treat Cancer
FN Media Group Presents USA News Group News Commentary 
From PR Newswire
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. (NYSE:PFE) invites investors and the general public to listen to a webcast of a discussion with Charles Triano, Senior Vice President, Investor Relations, at the Cowen and Company 40th... 
From Business Wire News Releases
Thinking about trading options or stock in Bank of America, Deere & Company, Pfizer, Tesla, or UnitedHealth Group?
InvestorsObserver issues critical PriceWatch Alerts for BAC, DE, PFE, TSLA, and UNH. 
From PR Newswire
European Commission Approves VYNDAQEL®, the First Treatment in the EU for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has approved VYNDAQEL® (tafamidis), a once-daily 61 mg oral capsule, for the treatment of wild-type or hereditary transthyretin... 
From Business Wire News Releases
Pediatric Brain Tumor Drug Market Is Growing Continuously and Could Reach US$1,659.4 Million by 2023
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Pediatric Brain Tumor Drug Market is Growing Continuously and Could Reach US$1,659.4 Million by 2023
Financialnewsmedia.com News Commentary 
From PR Newswire
XTANDI® (enzalutamide) Demonstrates Significant Improvement in Overall Survival in Phase 3 PROSPER Trial of Patients with nmCRPC
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Pfizer Inc. (NYSE: PFE) announced today results of the final overall survival (OS) analysis from the Phase 3... 
From PR Newswire
Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, RUXIENCE™ (rituximab)
Pfizer Inc. (NYSE: PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing... 
From Business Wire News Releases
Melanie Ivarsson, Ph.D. Joins Moderna as Chief Development Officer
Melanie Ivarsson, Ph.D. joins Moderna as Chief Development Officer. 
From Business Wire News Releases
PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2019 RESULTS
Pfizer Inc. (NYSE: PFE) reported financial results for fourth-quarter and full-year 2019 and provided 2020 financial guidance. 
From Business Wire News Releases
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.